If you or a loved one have been diagnosed with prostate cancer, you may be offered hormone therapy to treat it. Increasingly, hormone therapy is the treatment of choice, rather than surgery. Surgery to reduce hormone levels may only be offered if the cancer has spread to other areas or is...
Hormone therapy for prostate cancer has come a long way in the past few decades. Not so long ago, the only hormonal treatment for this disease was drastic: an orchiectomy, the surgical removal of the testicles. Now we have a number of medications -- available as pills, injections, and imp...
Doctors don’t know how long hormone therapy works to keepprostate cancerin check. So, while you take it, your doctor will regularly draw blood to check your PSA levels. Undetectable or low PSA levels usually mean that the treatment is working. If your PSA levels go up, it’s a sign ...
Treating high-risk prostate cancer patients with radiation therapy in conjunction with hormone therapy for more than 1 year allows patients to live longer and to achieve better PSA control, according to a study from the BC Cancer Agency, Victoria, British Columbia....
It is prevent androgens from encouraging prostate cancer cell growth Spironolactone (Aldactone)- It is mainly used for the treatment of women problems related to hormones . If a women has the problem such as- Acne and excessive body hair. Infertility etc People transitioning may take it to ...
▪ Studies reported at the Symposium demonstrated excellent results for the use of enzyme inhibitor agents, androgen receptor antagonists and azacitidine in the treatment of hormone‐refractory prostate cancer. Laino,Charlene - 《Oncology Times Uk》 被引量: 0发表: 2009年 Dietary Methionine Restriction...
Hormone-targeted treatment has previously been linked to a higher risk of diabetes and heart disease. Azoulay and his colleagues took UK data on 10,250 men who were diagnosed with prostate cancer between 1997 and 2008. The men were followed for an average of just over four years after their...
UK NICE guidance recommends FIRMAGON®(degarelix) for the treatment of advanced hormone-dependent prostate cancer only in people with spinalWEST DRAYTON, England--(BUSINESS WIRE)--The National Institute for Health and Care Excellence (NICE) today issued its Final Appraisal Determination (FAD)...
The androgen deprivation therapy (ADT), which has been specifically recommended for those with hormone-sensitive cases of the disease, is now the first oral treatment of its kind to be approved by the agency. Prostate cancer is the most common cancer in men in the UK, with appr...
New progress in treatment of hormone-refractory prostate cancer : The Lancet Oncologyerrorshealth insurance payorsAhmad K.doi:10.1016/S1470-2045(04)01641-9Khabir AhmadElsevier Ltd.Lancet OncologyAhmad K: New progress in treatment of hormone-refractory prostate cancer. Lancet Oncol 5: 706, 2004....